Anemia News and Research

RSS
Anemia is a decrease in normal number of red blood cells (RBCs) or less than the normal quantity of hemoglobin in the blood. However, it can include decreased oxygen-binding ability of each hemoglobin molecule due to deformity or lack in numerical development as in some other types of hemoglobin deficiency. The three main classes of anemia include excessive blood loss (acutely such as a hemorrhage or chronically through low-volume loss), excessive blood cell destruction (hemolysis) or deficient red blood cell production (ineffective hematopoiesis). Anemia is the most common disorder of the blood. There are several kinds of anemia, produced by a variety of underlying causes. Anemia can be classified in a variety of ways, based on the morphology of RBCs, underlying etiologic mechanisms, and discernible clinical spectra, to mention a few.
Millennium presents VELCADE Phase III trial data in multiple myeloma at IMW meeting

Millennium presents VELCADE Phase III trial data in multiple myeloma at IMW meeting

AGA's cutting-edge research on GI disorders to be presented at DDW 2011

AGA's cutting-edge research on GI disorders to be presented at DDW 2011

Millennium presents three studies in relapsed multiple myeloma at IMW meeting

Millennium presents three studies in relapsed multiple myeloma at IMW meeting

Synthetic blood saves life

Synthetic blood saves life

FibroGen announces proof-of-principle for FG-4592 Phase 2 study in hemodialysis patients

FibroGen announces proof-of-principle for FG-4592 Phase 2 study in hemodialysis patients

RBC transfusion linked to improved survival after intracerebral hemorrhage

RBC transfusion linked to improved survival after intracerebral hemorrhage

Low vitamin D levels linked to anemia in children

Low vitamin D levels linked to anemia in children

Babies born to obese mothers may face risk of iron deficiency

Babies born to obese mothers may face risk of iron deficiency

3D models prove useful in neurosurgical planning

3D models prove useful in neurosurgical planning

New guide to help cancer patients manage symptoms, side effects

New guide to help cancer patients manage symptoms, side effects

Researchers unravel mechanism behind sickle hemoglobin protection against malaria

Researchers unravel mechanism behind sickle hemoglobin protection against malaria

Antiviral Drugs Advisory Committee recommends FDA to approve telaprevir for hepatitis C

Antiviral Drugs Advisory Committee recommends FDA to approve telaprevir for hepatitis C

Takeda, Affymax announce additional peginesatide Phase 3 study results in dialysis patients

Takeda, Affymax announce additional peginesatide Phase 3 study results in dialysis patients

Five Loyola employees donate kidneys to complete strangers

Five Loyola employees donate kidneys to complete strangers

Tarix begins patient enrollment for TXA127 Phase 1 study in DCBT

Tarix begins patient enrollment for TXA127 Phase 1 study in DCBT

FDA supports new Hepatitis C drug from Vertex Pharmaceuticals

FDA supports new Hepatitis C drug from Vertex Pharmaceuticals

Millennium submits two VELCADE sNDAs to FDA

Millennium submits two VELCADE sNDAs to FDA

Rwanda, QIAGEN and Merck launch comprehensive national cervical cancer prevention program

Rwanda, QIAGEN and Merck launch comprehensive national cervical cancer prevention program

The Dannon Company launches new health and nutrition campaign for Californians

The Dannon Company launches new health and nutrition campaign for Californians

Researchers discover new compound to fight against shingles

Researchers discover new compound to fight against shingles

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.